Tag: AAN 2024
Study elucidates how patient age and electrode connectivity impact cognitive effects...
A study presented at the recent American Academy of Neurology (AAN) annual meeting (13–18 April, Denver, USA) has gone some way to elucidating how...
Cognito announces OVERTURE II results indicating durable effects of Spectris treatment...
Cognito Therapeutics has announced treatment results from OVERTURE II—an open-label extension (OLE) study of Spectris, the company’s potential disease-modifying therapy for the treatment of...
